Scott Schoenhaus
Stock Analyst at KeyBanc
(0.24)
# 4,581
Out of 5,060 analysts
207
Total ratings
37.3%
Success rate
-6.9%
Average return
Main Sectors:
Stocks Rated by Scott Schoenhaus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABSI Absci | Reiterated: Buy | $9 → $20 | $8.25 | +142.42% | 7 | Oct 16, 2026 | |
| CERT Certara | Reiterated: Buy | $8 → $12 | $9.37 | +28.07% | 10 | Oct 16, 2026 | |
| HNGE Hinge Health | Reiterated: Buy | $125 → $140 | $99.16 | +41.19% | 6 | Oct 16, 2026 | |
| SDGR Schrödinger | Reiterated: Buy | $20 → $32 | $22.60 | +41.59% | 13 | Oct 16, 2026 | |
| WAY Waystar Holding | Reiterated: Buy | $30 → $35 | $27.36 | +27.92% | 3 | Oct 16, 2026 | |
| IDXX IDEXX Laboratories | Initiated Coverage: Hold | n/a | $560.36 | - | 1 | Oct 12, 2026 | |
| OMCL Omnicell | Reiterated: Buy | $65 | $35.39 | +83.67% | 17 | Aug 24, 2026 | |
| HQY HealthEquity | Reiterated: Buy | $125 | $92.09 | +35.74% | 17 | Aug 18, 2026 | |
| LFMD LifeMD | Reiterated: Buy | $5 | $2.34 | +113.68% | 9 | Aug 7, 2026 | |
| ELAN Elanco Animal Health | Reiterated: Buy | $29 → $30 | $23.55 | +27.39% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $35 | $26.86 | +30.31% | 14 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $22.43 | - | 10 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $30.97 | - | 12 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $79.38 | - | 1 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $32 → $12 | $10.94 | +9.69% | 14 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.67 | - | 5 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.98 | - | 11 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.36 | - | 10 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.73 | - | 7 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $310.36 | - | 17 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $5 | $11.80 | n/a | 8 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $11.74 | n/a | 1 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $10 | $3.47 | n/a | 7 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $5.00 | n/a | 1 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $175 → $250 | $266.90 | n/a | 3 | Apr 16, 2021 |
Absci
Oct 16, 2026
Reiterated: Buy
Price Target: $9 → $20
Current: $8.25
Upside: +142.42%
Certara
Oct 16, 2026
Reiterated: Buy
Price Target: $8 → $12
Current: $9.37
Upside: +28.07%
Hinge Health
Oct 16, 2026
Reiterated: Buy
Price Target: $125 → $140
Current: $99.16
Upside: +41.19%
Schrödinger
Oct 16, 2026
Reiterated: Buy
Price Target: $20 → $32
Current: $22.60
Upside: +41.59%
Waystar Holding
Oct 16, 2026
Reiterated: Buy
Price Target: $30 → $35
Current: $27.36
Upside: +27.92%
IDEXX Laboratories
Oct 12, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $560.36
Upside: -
Omnicell
Aug 24, 2026
Reiterated: Buy
Price Target: $65
Current: $35.39
Upside: +83.67%
HealthEquity
Aug 18, 2026
Reiterated: Buy
Price Target: $125
Current: $92.09
Upside: +35.74%
LifeMD
Aug 7, 2026
Reiterated: Buy
Price Target: $5
Current: $2.34
Upside: +113.68%
Elanco Animal Health
Aug 6, 2026
Reiterated: Buy
Price Target: $29 → $30
Current: $23.55
Upside: +27.39%
Jul 13, 2026
Reiterated: Buy
Price Target: $28 → $35
Current: $26.86
Upside: +30.31%
Jun 2, 2026
Downgraded: Hold
Price Target: n/a
Current: $22.43
Upside: -
May 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $30.97
Upside: -
May 8, 2026
Reiterated: Hold
Price Target: n/a
Current: $79.38
Upside: -
Apr 13, 2026
Rated: Buy
Price Target: $32 → $12
Current: $10.94
Upside: +9.69%
Feb 27, 2026
Reiterated: Hold
Price Target: n/a
Current: $5.67
Upside: -
Feb 19, 2026
Downgraded: Hold
Price Target: n/a
Current: $8.98
Upside: -
Jan 8, 2026
Rated: Hold
Price Target: n/a
Current: $3.36
Upside: -
Jan 8, 2026
Rated: Hold
Price Target: n/a
Current: $1.73
Upside: -
Dec 12, 2025
Downgraded: Hold
Price Target: n/a
Current: $310.36
Upside: -
Apr 16, 2025
Reiterated: Buy
Price Target: $4 → $5
Current: $11.80
Upside: n/a
Apr 8, 2025
Initiated Coverage: Buy
Price Target: $9
Current: $11.74
Upside: n/a
Jan 8, 2025
Reiterated: Buy
Price Target: $12 → $10
Current: $3.47
Upside: n/a
Sep 15, 2022
Initiated Coverage: Hold
Price Target: n/a
Current: $5.00
Upside: n/a
Apr 16, 2021
Upgraded: Buy
Price Target: $175 → $250
Current: $266.90
Upside: n/a